NuVasive (NUVA) is down 10.8%, and Medtronic (MDT) is down 1.6%, after a jury found the...
Wednesday, September 21, 2011, 2:46 PM ETNuVasive (NUVA) is down 10.8%, and Medtronic (MDT) is down 1.6%, after a jury found the companies guilty of infringing each others' patents, but awarded Medtronic far more in damages. However, Jefferies remains bullish on NuVasive, predicting market share gains for the company's XLIF spinal procedure will allow it to beat guidance.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles